Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

6-Nitroquinazolines with dual TNF-alpha production/T-cell proliferation-suppressive effects

Dec. 2, 1999

Fused thiophenes from Ono inhibit IL-6 and/or IL-12 production

Dec. 2, 1999

Potent, selective, orally active and nonulcerogenic COX-2 inhibitor identified at Merck Frosst

Dec. 1, 1999

MMP inhibitors in early development at Sankyo

Dec. 1, 1999

Deracoxib may be suitable for once-daily dosing according to studies in dogs

Nov. 30, 1999

IDEC-131: pharmacokinetics and pharmacodynamics in monkeys given repeated infusions

Nov. 30, 1999

Enrollment completed in Inflammatics' phase I/II trial of LeukoVAX in RA

Nov. 29, 1999

GlycoDesign and Seikagaku collaborate on antiinflammatory drugs

Nov. 29, 1999

Biomatrix regains exclusive marketing rights to Synvisc in Canada

Nov. 29, 1999

Novel antiinflammatory/analgesic designed at Chinese university

Nov. 25, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...